Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of Acetaldehyde in Oral Carcinogenesis
NCT05973656Recruiting
- Sponsor
- Masonic Cancer Center
- Start
- Jul 2022
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Masonic Cancer Center. Primary endpoint: Acetaldehyde exposure to the oral cavity at 6 hours. Started Jul 2022; status: recruiting.
Beyond the preview
Go deeper on NCT05973656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05973656.